ArticleFrontiers in immunology2025

CEACAM6 as a machine learning derived immune biomarker for predicting neoadjuvant chemotherapy response in HR+/HER2- breast cancer.

Dalang Fang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.